+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Formulation Development Outsourcing Market by Service Type (Analytical Development, Formulation Development, Pre Formulation), Dosage Form (Inhalation, Oral Liquid, Oral Solid), Contract Model, Therapeutic Area - Global Forecast 2025-2030- Product Image
Formulation Development Outsourcing Market by Service Type (Analytical Development, Formulation Development, Pre Formulation), Dosage Form (Inhalation, Oral Liquid, Oral Solid), Contract Model, Therapeutic Area - Global Forecast 2025-2030- Product Image
Sale

Formulation Development Outsourcing Market by Service Type (Analytical Development, Formulation Development, Pre Formulation), Dosage Form (Inhalation, Oral Liquid, Oral Solid), Contract Model, Therapeutic Area - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666113
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Formulation Development Outsourcing Market continues to evolve as pharmaceutical companies increasingly seek expertise, innovation, and rapid turnaround from external partners to keep pace with complex drug development challenges.

Market Snapshot: Formulation Development Outsourcing Market

The global formulation development outsourcing market grew from USD 43.76 billion in 2024 to USD 48.24 billion in 2025 and is forecast to reach USD 77.34 billion by 2030, registering a CAGR of 9.95%. Expansion in biopharma R&D investments, the demand for advanced drug delivery systems, and shifting regulatory requirements are reinforcing the strategic importance of external development partners. This market enables pharmaceutical organizations to accelerate commercialization, address technical challenges associated with novel molecules, and adapt to dynamic compliance landscapes with efficiency.

Scope & Segmentation

This report provides detailed segmentation and coverage, equipping decision-makers with targeted insights into outsourced formulation development activities:

  • Service Types: Analytical development, formulation development, pre-formulation, regulatory filing support, stability studies.
  • Dosage Forms: Inhalation, oral liquid, oral solid, parenteral (intramuscular, intravenous, subcutaneous), topical (cream, gel, ointment), transdermal.
  • Contract Models: Fixed price, risk sharing, time and materials.
  • Therapeutic Areas: Cardiovascular, central nervous system, infectious diseases, metabolic disorders, oncology.
  • Geographic Regions: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe Middle East & Africa (with selected markets such as United Kingdom, Germany, France, United Arab Emirates, South Africa, and others), Asia-Pacific (including China, India, Japan, Australia, and more).
  • Featured Companies: Leading participants include Catalent, Inc., Thermo Fisher Scientific Inc., Lonza Group AG, Samsung Biologics Co., Ltd., Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Siegfried Holding AG, Jubilant Life Sciences Limited, PCI Services LLC, and Aenova Holding GmbH.
  • Technology Utilization: Innovative delivery platforms, predictive analytics, artificial intelligence, high-throughput analytical techniques, and advanced excipient libraries.

Key Takeaways for Senior Decision-Makers

  • Outsourced formulation development enables market entrants and established players to access specialized expertise and technology, optimizing drug performance and regulatory readiness.
  • Integration between analytical rigor and formulation know-how supports seamless project progression across development milestones with quality and efficiency.
  • Strategic partnerships are shifting towards collaborative and risk-sharing models, aligning provider incentives with project outcomes and strengthening long-term innovation pipelines.
  • Segment-specific capabilities—such as the ability to address complex biologics, advanced delivery challenges, or strict sterility requirements—often determine partner selection and project success.
  • Differentiated approaches to regional operations, including local regulatory navigation and technology transfer in high-growth APAC markets, are driving resilience and growth.

Tariff Impact: Navigating Regulatory and Geopolitical Pressures

The 2025 United States tariffs have imposed cost pressures on formulation development organizations reliant on global material sourcing. Providers are responding by reevaluating supplier networks, considering onshore expansion, and adjusting supply chain strategies for enhanced resilience. These shifts require strategic investments but help safeguard project timelines and compliance amid fluid trade environments.

Methodology & Data Sources

This analysis synthesizes primary interviews with industry executives, input from regulatory consultants, and peer-reviewed literature. Proprietary databases track mergers, acquisitions, and partnership activity, while structured interviews provide context on evolving business models and technology integration. Quantitative and qualitative insights are triangulated for robust, validated findings.

Why This Report Matters: Strategic Value for Decision-Makers

  • Enables clear benchmarking of outsourcing strategies and contract development organization capabilities across regions and therapeutic areas.
  • Equips leaders with actionable insights on technology adoption, partnership models, and supply chain agility to future-proof development operations.

Conclusion

Formulation development outsourcing has become a cornerstone for biopharma innovation, enabling sponsors to drive efficiency and address complex challenges. Strategic partnerships and a focus on technology and operational flexibility are critical for sustained market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of AI-driven formulation screening platforms to accelerate candidate optimization and reduce development timelines
5.2. Integration of continuous manufacturing technologies by CDMOs to enhance scalability and comply with evolving regulatory standards
5.3. Expansion of high-potency API formulation services in outsourced facilities to meet growing oncology and cytotoxic drug demands
5.4. Growing partnerships between specialized biologics CDMOs and pharma companies for mRNA vaccine formulation and delivery
5.5. Incorporation of predictive modeling and digital twin technologies into formulation development workflows to improve stability outcomes
5.6. Increasing focus on green chemistry and sustainable excipient selection in outsourced formulation to reduce environmental impact
5.7. Rising adoption of 3D printing techniques in contract formulation to enable personalized dosage forms and on-demand manufacturing
5.8. Investment in advanced cold chain logistics by outsourcing providers to support temperature-sensitive biologics and large molecule distribution
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Formulation Development Outsourcing Market, by Service Type
8.1. Introduction
8.2. Analytical Development
8.2.1. Method Development
8.2.2. Method Validation
8.2.3. Sample Analysis
8.3. Formulation Development
8.4. Pre Formulation
8.5. Regulatory Filing Support
8.6. Stability Studies
9. Formulation Development Outsourcing Market, by Dosage Form
9.1. Introduction
9.2. Inhalation
9.3. Oral Liquid
9.4. Oral Solid
9.5. Parenteral
9.5.1. Intramuscular
9.5.2. Intravenous
9.5.3. Subcutaneous
9.6. Topical
9.6.1. Cream
9.6.2. Gel
9.6.3. Ointment
9.7. Transdermal
10. Formulation Development Outsourcing Market, by Contract Model
10.1. Introduction
10.2. Fixed Price
10.3. Risk Sharing
10.4. Time And Materials
11. Formulation Development Outsourcing Market, by Therapeutic Area
11.1. Introduction
11.2. Cardiovascular
11.3. Central Nervous System
11.4. Infectious Diseases
11.5. Metabolic Disorders
11.6. Oncology
12. Americas Formulation Development Outsourcing Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Formulation Development Outsourcing Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Formulation Development Outsourcing Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Catalent, Inc.
15.3.2. Thermo Fisher Scientific Inc.
15.3.3. Lonza Group AG
15.3.4. Samsung Biologics Co., Ltd.
15.3.5. Recipharm AB
15.3.6. Vetter Pharma-Fertigung GmbH & Co. KG
15.3.7. Siegfried Holding AG
15.3.8. Jubilant Life Sciences Limited
15.3.9. PCI Services LLC
15.3.10. Aenova Holding GmbH
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2030 (%)
FIGURE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. FORMULATION DEVELOPMENT OUTSOURCING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. FORMULATION DEVELOPMENT OUTSOURCING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. FORMULATION DEVELOPMENT OUTSOURCING MARKET: RESEARCHAI
FIGURE 24. FORMULATION DEVELOPMENT OUTSOURCING MARKET: RESEARCHSTATISTICS
FIGURE 25. FORMULATION DEVELOPMENT OUTSOURCING MARKET: RESEARCHCONTACTS
FIGURE 26. FORMULATION DEVELOPMENT OUTSOURCING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. FORMULATION DEVELOPMENT OUTSOURCING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD VALIDATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METHOD VALIDATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SAMPLE ANALYSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FORMULATION DEVELOPMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PRE FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGULATORY FILING SUPPORT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY REGULATORY FILING SUPPORT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STABILITY STUDIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INHALATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INHALATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL LIQUID, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL SOLID, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ORAL SOLID, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY OINTMENT, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY OINTMENT, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TRANSDERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FIXED PRICE, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY FIXED PRICE, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RISK SHARING, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY RISK SHARING, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TIME AND MATERIALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TIME AND MATERIALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CENTRAL NERVOUS SYSTEM, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 97. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 98. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 99. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 100. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 111. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 112. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 113. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 114. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 115. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 116. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 117. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 118. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 119. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 120. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 121. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 122. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 123. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 124. CANADA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 125. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 126. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 127. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 128. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 129. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 130. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 131. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 132. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 133. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 134. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 135. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 136. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 137. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 138. MEXICO FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 139. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 140. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 141. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 142. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 143. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 144. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 145. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 146. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 147. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 148. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 149. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 150. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 153. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 154. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 155. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 156. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 157. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 158. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 159. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 160. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 161. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 162. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 163. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 164. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 165. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 166. ARGENTINA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 169. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 170. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 171. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 172. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 173. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 174. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 175. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 176. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 177. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 178. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 179. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 180. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 181. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 182. EUROPE, MIDDLE EAST & AFRICA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 184. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 186. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 187. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 188. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 189. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 190. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 191. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 192. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 193. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 195. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 196. UNITED KINGDOM FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 197. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 198. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 199. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 200. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 201. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 202. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 203. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 204. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 205. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 206. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 207. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 208. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 209. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 210. GERMANY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 211. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 212. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 213. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 214. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 215. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 216. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 217. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 218. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 219. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 220. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 221. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 222. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 223. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 224. FRANCE FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 225. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 226. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 227. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 228. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 229. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 230. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 231. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 232. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 233. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 234. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 235. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 236. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 237. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 238. RUSSIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 239. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 240. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 241. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 242. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 243. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 244. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 245. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 246. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 247. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 248. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 249. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 250. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 251. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 252. ITALY FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 253. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 254. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 255. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 256. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 257. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 258. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 259. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 260. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 261. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 262. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 263. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 264. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 265. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 266. SPAIN FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 267. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 268. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 269. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 270. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 271. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 272. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 273. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 274. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2018-2024 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY CONTRACT MODEL, 2025-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2018-2024 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY THERAPEUTIC AREA, 2025-2030 (USD MILLION)
TABLE 281. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 282. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 283. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2018-2024 (USD MILLION)
TABLE 284. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY ANALYTICAL DEVELOPMENT, 2025-2030 (USD MILLION)
TABLE 285. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 286. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 287. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2018-2024 (USD MILLION)
TABLE 288. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY PARENTERAL, 2025-2030 (USD MILLION)
TABLE 289. SAUDI ARABIA FORMULATION DEVELOPMENT OUTSOURCING MARKET SIZE, BY TOPICAL, 2018-

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Formulation Development Outsourcing market report include:
  • Catalent, Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • Samsung Biologics Co., Ltd.
  • Recipharm AB
  • Vetter Pharma-Fertigung GmbH & Co. KG
  • Siegfried Holding AG
  • Jubilant Life Sciences Limited
  • PCI Services LLC
  • Aenova Holding GmbH

Table Information

Report AttributeDetails
No. of Pages188
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 48.24 Billion
Forecasted Market Value ( USD ) by 2030 $ 77.34 Billion
Compound Annual Growth Rate9.9%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Formulation Development Outsourcing - Global Strategic Business Report - Product Image

Formulation Development Outsourcing - Global Strategic Business Report

  • Report
  • 389 Pages
  • Global
From
Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030 - Product Image

Formulation Development Outsourcing Market Size, Share & Trends Analysis Report by Service (Preformulation, Formulation Development), Formulation, Therapeutic Area, End-use, Region, with Growth Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Global Formulation Development Outsourcing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 164 Pages
  • Global
From
Formulation Development Outsourcing: Market Share, and Growth Analysis by Product Type (Oral, Injectable, Topical), Application, End User, Technology - Product Image

Formulation Development Outsourcing: Market Share, and Growth Analysis by Product Type (Oral, Injectable, Topical), Application, End User, Technology

  • Report
  • 150 Pages
  • Global
From
Formulation Development Outsourcing Market Report by Service, Dosage Form, Application, End User, and Region 2024-2032 - Product Image

Formulation Development Outsourcing Market Report by Service, Dosage Form, Application, End User, and Region 2024-2032

  • Report
  • 144 Pages
  • Global
From

About the Formulation Development Market

The Formulation Development market within the context of Pharmaceutical Manufacturing is a specialized sector of the industry that focuses on the development of drug formulations. This includes the process of creating a drug product that is suitable for its intended use, such as a tablet, capsule, or injectable. This process involves the selection of the active pharmaceutical ingredient, the selection of excipients, the design of the formulation, and the optimization of the manufacturing process. The goal of this process is to create a safe and effective drug product that meets the requirements of regulatory agencies. Formulation Development is a critical step in the drug development process, as it ensures that the drug product is safe and effective. It is also important for the successful commercialization of a drug product. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and AstraZeneca. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.